 | • レポートコード：MRC2-11QY02683 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、112ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は関節炎薬のグローバル市場について調査・分析したレポートです。種類別（合成DMARD、生物学的DMARD、NSAID、コルチコステロイド、鎮痛薬）市場規模、用途別（小売薬局、病院薬局、ドラッグストア、Eコマース）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別関節炎薬の競争状況、市場シェア ・世界の関節炎薬市場：種類別市場規模 2015年-2020年（合成DMARD、生物学的DMARD、NSAID、コルチコステロイド、鎮痛薬） ・世界の関節炎薬市場：種類別市場規模予測 2021年-2026年（合成DMARD、生物学的DMARD、NSAID、コルチコステロイド、鎮痛薬） ・世界の関節炎薬市場：用途別市場規模 2015年-2020年（小売薬局、病院薬局、ドラッグストア、Eコマース） ・世界の関節炎薬市場：用途別市場規模予測 2021年-2026年（小売薬局、病院薬局、ドラッグストア、Eコマース） ・北米の関節炎薬市場分析：米国、カナダ ・ヨーロッパの関節炎薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの関節炎薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の関節炎薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの関節炎薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Novartis、Eli Lilly、Celltrion、F. Hoffmann-La Roche、Pfizer、Johnson & Johnson、GSK ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Arthritis is condition that causes pain and inflammation in joints. Around 100 different types of arthritis related conditions present globally and it is one of the leading cause of disability worldwide. The most common types of arthritis includes: Psoriatic Arthritis, Rheumatoid Arthritis, Osteoarthritis, are among others.
Growing burden of incidence of osteoarthritis, psoriatic arthritis and rheumatoid arthritis patients are major factors driving the growth of global arthritis drugs market. According to CDC estimation from 2010-2012, about 52.5 million US adults had some form of arthritis conditions among them persons with age 65 or older reported higher prevalence of arthritis conditions than the other ages due to “wear and tear” on the joints. However, due to lack of proper medication to cure arthritis and higher cost of the medications are hindering the growth of this market over the forecast period.
Market Analysis and Insights: Global Arthritis Drug Market
The global Arthritis Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Arthritis Drug Scope and Market Size
Arthritis Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Arthritis Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Arthritis Drug market is segmented into
Synthetic DMARDs
Biological DMARDs
NSAIDs
Corticosteroids
Analgesics
Segment by Application, the Arthritis Drug market is segmented into
Retail Pharmacies
Hospital Pharmacies
Drug Stores
E-Commerce
Regional and Country-level Analysis
The Arthritis Drug market is analysed and market size information is provided by regions (countries).
The key regions covered in the Arthritis Drug market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Arthritis Drug Market Share Analysis
Arthritis Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Arthritis Drug business, the date to enter into the Arthritis Drug market, Arthritis Drug product introduction, recent developments, etc.
The major vendors covered:
Novartis
Eli Lilly
Celltrion
F. Hoffmann-La Roche
Pfizer
Johnson & Johnson
GSK
…
1 Study Coverage
1.1 Arthritis Drug Product Introduction
1.2 Market Segments
1.3 Key Arthritis Drug Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Arthritis Drug Market Size Growth Rate by Type
1.4.2 Synthetic DMARDs
1.4.3 Biological DMARDs
1.4.4 NSAIDs
1.4.5 Corticosteroids
1.4.6 Analgesics
1.5 Market by Application
1.5.1 Global Arthritis Drug Market Size Growth Rate by Application
1.5.2 Retail Pharmacies
1.5.3 Hospital Pharmacies
1.5.4 Drug Stores
1.5.5 E-Commerce
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Arthritis Drug Market Size, Estimates and Forecasts
2.1.1 Global Arthritis Drug Revenue 2015-2026
2.1.2 Global Arthritis Drug Sales 2015-2026
2.2 Global Arthritis Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Arthritis Drug Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Arthritis Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Arthritis Drug Competitor Landscape by Players
3.1 Arthritis Drug Sales by Manufacturers
3.1.1 Arthritis Drug Sales by Manufacturers (2015-2020)
3.1.2 Arthritis Drug Sales Market Share by Manufacturers (2015-2020)
3.2 Arthritis Drug Revenue by Manufacturers
3.2.1 Arthritis Drug Revenue by Manufacturers (2015-2020)
3.2.2 Arthritis Drug Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Arthritis Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Arthritis Drug Revenue in 2019
3.2.5 Global Arthritis Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Arthritis Drug Price by Manufacturers
3.4 Arthritis Drug Manufacturing Base Distribution, Product Types
3.4.1 Arthritis Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Arthritis Drug Product Type
3.4.3 Date of International Manufacturers Enter into Arthritis Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Arthritis Drug Market Size by Type (2015-2020)
4.1.1 Global Arthritis Drug Sales by Type (2015-2020)
4.1.2 Global Arthritis Drug Revenue by Type (2015-2020)
4.1.3 Arthritis Drug Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Arthritis Drug Market Size Forecast by Type (2021-2026)
4.2.1 Global Arthritis Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Arthritis Drug Revenue Forecast by Type (2021-2026)
4.2.3 Arthritis Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Arthritis Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Arthritis Drug Market Size by Application (2015-2020)
5.1.1 Global Arthritis Drug Sales by Application (2015-2020)
5.1.2 Global Arthritis Drug Revenue by Application (2015-2020)
5.1.3 Arthritis Drug Price by Application (2015-2020)
5.2 Arthritis Drug Market Size Forecast by Application (2021-2026)
5.2.1 Global Arthritis Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Arthritis Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Arthritis Drug Price Forecast by Application (2021-2026)
6 North America
6.1 North America Arthritis Drug by Country
6.1.1 North America Arthritis Drug Sales by Country
6.1.2 North America Arthritis Drug Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Arthritis Drug Market Facts & Figures by Type
6.3 North America Arthritis Drug Market Facts & Figures by Application
7 Europe
7.1 Europe Arthritis Drug by Country
7.1.1 Europe Arthritis Drug Sales by Country
7.1.2 Europe Arthritis Drug Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Arthritis Drug Market Facts & Figures by Type
7.3 Europe Arthritis Drug Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Arthritis Drug by Region
8.1.1 Asia Pacific Arthritis Drug Sales by Region
8.1.2 Asia Pacific Arthritis Drug Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Arthritis Drug Market Facts & Figures by Type
8.3 Asia Pacific Arthritis Drug Market Facts & Figures by Application
9 Latin America
9.1 Latin America Arthritis Drug by Country
9.1.1 Latin America Arthritis Drug Sales by Country
9.1.2 Latin America Arthritis Drug Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Arthritis Drug Market Facts & Figures by Type
9.3 Central & South America Arthritis Drug Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Arthritis Drug by Country
10.1.1 Middle East and Africa Arthritis Drug Sales by Country
10.1.2 Middle East and Africa Arthritis Drug Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Arthritis Drug Market Facts & Figures by Type
10.3 Middle East and Africa Arthritis Drug Market Facts & Figures by Application
11 Company Profiles
11.1 Novartis
11.1.1 Novartis Corporation Information
11.1.2 Novartis Description and Business Overview
11.1.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Novartis Arthritis Drug Products Offered
11.1.5 Novartis Related Developments
11.2 Eli Lilly
11.2.1 Eli Lilly Corporation Information
11.2.2 Eli Lilly Description and Business Overview
11.2.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Eli Lilly Arthritis Drug Products Offered
11.2.5 Eli Lilly Related Developments
11.3 Celltrion
11.3.1 Celltrion Corporation Information
11.3.2 Celltrion Description and Business Overview
11.3.3 Celltrion Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Celltrion Arthritis Drug Products Offered
11.3.5 Celltrion Related Developments
11.4 F. Hoffmann-La Roche
11.4.1 F. Hoffmann-La Roche Corporation Information
11.4.2 F. Hoffmann-La Roche Description and Business Overview
11.4.3 F. Hoffmann-La Roche Sales, Revenue and Gross Margin (2015-2020)
11.4.4 F. Hoffmann-La Roche Arthritis Drug Products Offered
11.4.5 F. Hoffmann-La Roche Related Developments
11.5 Pfizer
11.5.1 Pfizer Corporation Information
11.5.2 Pfizer Description and Business Overview
11.5.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Pfizer Arthritis Drug Products Offered
11.5.5 Pfizer Related Developments
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Corporation Information
11.6.2 Johnson & Johnson Description and Business Overview
11.6.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Johnson & Johnson Arthritis Drug Products Offered
11.6.5 Johnson & Johnson Related Developments
11.7 GSK
11.7.1 GSK Corporation Information
11.7.2 GSK Description and Business Overview
11.7.3 GSK Sales, Revenue and Gross Margin (2015-2020)
11.7.4 GSK Arthritis Drug Products Offered
11.7.5 GSK Related Developments
11.1 Novartis
11.1.1 Novartis Corporation Information
11.1.2 Novartis Description and Business Overview
11.1.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Novartis Arthritis Drug Products Offered
11.1.5 Novartis Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Arthritis Drug Market Estimates and Projections by Region
12.1.1 Global Arthritis Drug Sales Forecast by Regions 2021-2026
12.1.2 Global Arthritis Drug Revenue Forecast by Regions 2021-2026
12.2 North America Arthritis Drug Market Size Forecast (2021-2026)
12.2.1 North America: Arthritis Drug Sales Forecast (2021-2026)
12.2.2 North America: Arthritis Drug Revenue Forecast (2021-2026)
12.2.3 North America: Arthritis Drug Market Size Forecast by Country (2021-2026)
12.3 Europe Arthritis Drug Market Size Forecast (2021-2026)
12.3.1 Europe: Arthritis Drug Sales Forecast (2021-2026)
12.3.2 Europe: Arthritis Drug Revenue Forecast (2021-2026)
12.3.3 Europe: Arthritis Drug Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Arthritis Drug Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Arthritis Drug Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Arthritis Drug Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Arthritis Drug Market Size Forecast by Region (2021-2026)
12.5 Latin America Arthritis Drug Market Size Forecast (2021-2026)
12.5.1 Latin America: Arthritis Drug Sales Forecast (2021-2026)
12.5.2 Latin America: Arthritis Drug Revenue Forecast (2021-2026)
12.5.3 Latin America: Arthritis Drug Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Arthritis Drug Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Arthritis Drug Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Arthritis Drug Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Arthritis Drug Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Arthritis Drug Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Arthritis Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Arthritis Drug Market Segments
Table 2. Ranking of Global Top Arthritis Drug Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Arthritis Drug Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of Synthetic DMARDs
Table 5. Major Manufacturers of Biological DMARDs
Table 6. Major Manufacturers of NSAIDs
Table 7. Major Manufacturers of Corticosteroids
Table 8. Major Manufacturers of Analgesics
Table 9. Global Arthritis Drug Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 10. Global Arthritis Drug Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 11. Global Arthritis Drug Sales by Regions 2015-2020 (K Pcs)
Table 12. Global Arthritis Drug Sales Market Share by Regions (2015-2020)
Table 13. Global Arthritis Drug Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global Arthritis Drug Sales by Manufacturers (2015-2020) (K Pcs)
Table 15. Global Arthritis Drug Sales Share by Manufacturers (2015-2020)
Table 16. Global Arthritis Drug Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global Arthritis Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Arthritis Drug as of 2019)
Table 18. Arthritis Drug Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. Arthritis Drug Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers Arthritis Drug Price (2015-2020) (USD/Pcs)
Table 21. Arthritis Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Arthritis Drug Product Type
Table 23. Date of International Manufacturers Enter into Arthritis Drug Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Arthritis Drug Sales by Type (2015-2020) (K Pcs)
Table 26. Global Arthritis Drug Sales Share by Type (2015-2020)
Table 27. Global Arthritis Drug Revenue by Type (2015-2020) (US$ Million)
Table 28. Global Arthritis Drug Revenue Share by Type (2015-2020)
Table 29. Arthritis Drug Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 30. Global Arthritis Drug Sales by Application (2015-2020) (K Pcs)
Table 31. Global Arthritis Drug Sales Share by Application (2015-2020)
Table 32. North America Arthritis Drug Sales by Country (2015-2020) (K Pcs)
Table 33. North America Arthritis Drug Sales Market Share by Country (2015-2020)
Table 34. North America Arthritis Drug Revenue by Country (2015-2020) (US$ Million)
Table 35. North America Arthritis Drug Revenue Market Share by Country (2015-2020)
Table 36. North America Arthritis Drug Sales by Type (2015-2020) (K Pcs)
Table 37. North America Arthritis Drug Sales Market Share by Type (2015-2020)
Table 38. North America Arthritis Drug Sales by Application (2015-2020) (K Pcs)
Table 39. North America Arthritis Drug Sales Market Share by Application (2015-2020)
Table 40. Europe Arthritis Drug Sales by Country (2015-2020) (K Pcs)
Table 41. Europe Arthritis Drug Sales Market Share by Country (2015-2020)
Table 42. Europe Arthritis Drug Revenue by Country (2015-2020) (US$ Million)
Table 43. Europe Arthritis Drug Revenue Market Share by Country (2015-2020)
Table 44. Europe Arthritis Drug Sales by Type (2015-2020) (K Pcs)
Table 45. Europe Arthritis Drug Sales Market Share by Type (2015-2020)
Table 46. Europe Arthritis Drug Sales by Application (2015-2020) (K Pcs)
Table 47. Europe Arthritis Drug Sales Market Share by Application (2015-2020)
Table 48. Asia Pacific Arthritis Drug Sales by Region (2015-2020) (K Pcs)
Table 49. Asia Pacific Arthritis Drug Sales Market Share by Region (2015-2020)
Table 50. Asia Pacific Arthritis Drug Revenue by Region (2015-2020) (US$ Million)
Table 51. Asia Pacific Arthritis Drug Revenue Market Share by Region (2015-2020)
Table 52. Asia Pacific Arthritis Drug Sales by Type (2015-2020) (K Pcs)
Table 53. Asia Pacific Arthritis Drug Sales Market Share by Type (2015-2020)
Table 54. Asia Pacific Arthritis Drug Sales by Application (2015-2020) (K Pcs)
Table 55. Asia Pacific Arthritis Drug Sales Market Share by Application (2015-2020)
Table 56. Latin America Arthritis Drug Sales by Country (2015-2020) (K Pcs)
Table 57. Latin America Arthritis Drug Sales Market Share by Country (2015-2020)
Table 58. Latin Americaa Arthritis Drug Revenue by Country (2015-2020) (US$ Million)
Table 59. Latin America Arthritis Drug Revenue Market Share by Country (2015-2020)
Table 60. Latin America Arthritis Drug Sales by Type (2015-2020) (K Pcs)
Table 61. Latin America Arthritis Drug Sales Market Share by Type (2015-2020)
Table 62. Latin America Arthritis Drug Sales by Application (2015-2020) (K Pcs)
Table 63. Latin America Arthritis Drug Sales Market Share by Application (2015-2020)
Table 64. Middle East and Africa Arthritis Drug Sales by Country (2015-2020) (K Pcs)
Table 65. Middle East and Africa Arthritis Drug Sales Market Share by Country (2015-2020)
Table 66. Middle East and Africa Arthritis Drug Revenue by Country (2015-2020) (US$ Million)
Table 67. Middle East and Africa Arthritis Drug Revenue Market Share by Country (2015-2020)
Table 68. Middle East and Africa Arthritis Drug Sales by Type (2015-2020) (K Pcs)
Table 69. Middle East and Africa Arthritis Drug Sales Market Share by Type (2015-2020)
Table 70. Middle East and Africa Arthritis Drug Sales by Application (2015-2020) (K Pcs)
Table 71. Middle East and Africa Arthritis Drug Sales Market Share by Application (2015-2020)
Table 72. Novartis Corporation Information
Table 73. Novartis Description and Major Businesses
Table 74. Novartis Arthritis Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 75. Novartis Product
Table 76. Novartis Recent Development
Table 77. Eli Lilly Corporation Information
Table 78. Eli Lilly Description and Major Businesses
Table 79. Eli Lilly Arthritis Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 80. Eli Lilly Product
Table 81. Eli Lilly Recent Development
Table 82. Celltrion Corporation Information
Table 83. Celltrion Description and Major Businesses
Table 84. Celltrion Arthritis Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 85. Celltrion Product
Table 86. Celltrion Recent Development
Table 87. F. Hoffmann-La Roche Corporation Information
Table 88. F. Hoffmann-La Roche Description and Major Businesses
Table 89. F. Hoffmann-La Roche Arthritis Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 90. F. Hoffmann-La Roche Product
Table 91. F. Hoffmann-La Roche Recent Development
Table 92. Pfizer Corporation Information
Table 93. Pfizer Description and Major Businesses
Table 94. Pfizer Arthritis Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 95. Pfizer Product
Table 96. Pfizer Recent Development
Table 97. Johnson & Johnson Corporation Information
Table 98. Johnson & Johnson Description and Major Businesses
Table 99. Johnson & Johnson Arthritis Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 100. Johnson & Johnson Product
Table 101. Johnson & Johnson Recent Development
Table 102. GSK Corporation Information
Table 103. GSK Description and Major Businesses
Table 104. GSK Arthritis Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 105. GSK Product
Table 106. GSK Recent Development
Table 107. Global Arthritis Drug Sales Forecast by Regions (2021-2026) (K Pcs)
Table 108. Global Arthritis Drug Sales Market Share Forecast by Regions (2021-2026)
Table 109. Global Arthritis Drug Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 110. Global Arthritis Drug Revenue Market Share Forecast by Regions (2021-2026)
Table 111. North America: Arthritis Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 112. North America: Arthritis Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 113. Europe: Arthritis Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 114. Europe: Arthritis Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 115. Asia Pacific: Arthritis Drug Sales Forecast by Region (2021-2026) (K Pcs)
Table 116. Asia Pacific: Arthritis Drug Revenue Forecast by Region (2021-2026) (US$ Million)
Table 117. Latin America: Arthritis Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 118. Latin America: Arthritis Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 119. Middle East and Africa: Arthritis Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 120. Middle East and Africa: Arthritis Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 121. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 122. Key Challenges
Table 123. Market Risks
Table 124. Main Points Interviewed from Key Arthritis Drug Players
Table 125. Arthritis Drug Customers List
Table 126. Arthritis Drug Distributors List
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Arthritis Drug Product Picture
Figure 2. Global Arthritis Drug Sales Market Share by Type in 2020 & 2026
Figure 3. Synthetic DMARDs Product Picture
Figure 4. Biological DMARDs Product Picture
Figure 5. NSAIDs Product Picture
Figure 6. Corticosteroids Product Picture
Figure 7. Analgesics Product Picture
Figure 8. Global Arthritis Drug Sales Market Share by Application in 2020 & 2026
Figure 9. Retail Pharmacies
Figure 10. Hospital Pharmacies
Figure 11. Drug Stores
Figure 12. E-Commerce
Figure 13. Arthritis Drug Report Years Considered
Figure 14. Global Arthritis Drug Market Size 2015-2026 (US$ Million)
Figure 15. Global Arthritis Drug Sales 2015-2026 (K Pcs)
Figure 16. Global Arthritis Drug Market Size Market Share by Region: 2020 Versus 2026
Figure 17. Global Arthritis Drug Sales Market Share by Region (2015-2020)
Figure 18. Global Arthritis Drug Sales Market Share by Region in 2019
Figure 19. Global Arthritis Drug Revenue Market Share by Region (2015-2020)
Figure 20. Global Arthritis Drug Revenue Market Share by Region in 2019
Figure 21. Global Arthritis Drug Sales Share by Manufacturer in 2019
Figure 22. The Top 10 and 5 Players Market Share by Arthritis Drug Revenue in 2019
Figure 23. Arthritis Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 24. Global Arthritis Drug Sales Market Share by Type (2015-2020)
Figure 25. Global Arthritis Drug Sales Market Share by Type in 2019
Figure 26. Global Arthritis Drug Revenue Market Share by Type (2015-2020)
Figure 27. Global Arthritis Drug Revenue Market Share by Type in 2019
Figure 28. Global Arthritis Drug Market Share by Price Range (2015-2020)
Figure 29. Global Arthritis Drug Sales Market Share by Application (2015-2020)
Figure 30. Global Arthritis Drug Sales Market Share by Application in 2019
Figure 31. Global Arthritis Drug Revenue Market Share by Application (2015-2020)
Figure 32. Global Arthritis Drug Revenue Market Share by Application in 2019
Figure 33. North America Arthritis Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 34. North America Arthritis Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 35. North America Arthritis Drug Sales Market Share by Country in 2019
Figure 36. North America Arthritis Drug Revenue Market Share by Country in 2019
Figure 37. U.S. Arthritis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 38. U.S. Arthritis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. Canada Arthritis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 40. Canada Arthritis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. North America Arthritis Drug Market Share by Type in 2019
Figure 42. North America Arthritis Drug Market Share by Application in 2019
Figure 43. Europe Arthritis Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 44. Europe Arthritis Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 45. Europe Arthritis Drug Sales Market Share by Country in 2019
Figure 46. Europe Arthritis Drug Revenue Market Share by Country in 2019
Figure 47. Germany Arthritis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 48. Germany Arthritis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. France Arthritis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 50. France Arthritis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. U.K. Arthritis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 52. U.K. Arthritis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Italy Arthritis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 54. Italy Arthritis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Russia Arthritis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 56. Russia Arthritis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Europe Arthritis Drug Market Share by Type in 2019
Figure 58. Europe Arthritis Drug Market Share by Application in 2019
Figure 59. Asia Pacific Arthritis Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 60. Asia Pacific Arthritis Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 61. Asia Pacific Arthritis Drug Sales Market Share by Region in 2019
Figure 62. Asia Pacific Arthritis Drug Revenue Market Share by Region in 2019
Figure 63. China Arthritis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 64. China Arthritis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Japan Arthritis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 66. Japan Arthritis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. South Korea Arthritis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 68. South Korea Arthritis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. India Arthritis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 70. India Arthritis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Australia Arthritis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 72. Australia Arthritis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Taiwan Arthritis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 74. Taiwan Arthritis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Indonesia Arthritis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 76. Indonesia Arthritis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Thailand Arthritis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 78. Thailand Arthritis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Malaysia Arthritis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 80. Malaysia Arthritis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Philippines Arthritis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 82. Philippines Arthritis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Vietnam Arthritis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 84. Vietnam Arthritis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Asia Pacific Arthritis Drug Market Share by Type in 2019
Figure 86. Asia Pacific Arthritis Drug Market Share by Application in 2019
Figure 87. Latin America Arthritis Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 88. Latin America Arthritis Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 89. Latin America Arthritis Drug Sales Market Share by Country in 2019
Figure 90. Latin America Arthritis Drug Revenue Market Share by Country in 2019
Figure 91. Mexico Arthritis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 92. Mexico Arthritis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Brazil Arthritis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 94. Brazil Arthritis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Argentina Arthritis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 96. Argentina Arthritis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 97. Latin America Arthritis Drug Market Share by Type in 2019
Figure 98. Latin America Arthritis Drug Market Share by Application in 2019
Figure 99. Middle East and Africa Arthritis Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 100. Middle East and Africa Arthritis Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 101. Middle East and Africa Arthritis Drug Sales Market Share by Country in 2019
Figure 102. Middle East and Africa Arthritis Drug Revenue Market Share by Country in 2019
Figure 103. Turkey Arthritis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 104. Turkey Arthritis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Saudi Arabia Arthritis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 106. Saudi Arabia Arthritis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. U.A.E Arthritis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 108. U.A.E Arthritis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 109. Middle East and Africa Arthritis Drug Market Share by Type in 2019
Figure 110. Middle East and Africa Arthritis Drug Market Share by Application in 2019
Figure 111. North America Arthritis Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 112. North America Arthritis Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Europe Arthritis Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 114. Europe Arthritis Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Asia Pacific Arthritis Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 116. Asia Pacific Arthritis Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Latin America Arthritis Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 118. Latin America Arthritis Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Middle East and Africa Arthritis Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 120. Middle East and Africa Arthritis Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Porter's Five Forces Analysis
Figure 122. Channels of Distribution
Figure 123. Distributors Profiles
Figure 124. Bottom-up and Top-down Approaches for This Report
Figure 125. Data Triangulation
Figure 126. Key Executives Interviewed
血清反応陽性用関節リウマチ治療薬の世界市場（～2026年） Arthritis means inflammation in a joint. The inflammation is characterized by swelling, pain, and redness within the joint. This type of arthritis is known to cause chronic inflammatory disorder in the hands and feet. The Americas dominated the overall market in terms of revenue in 2016 owing to the…- 多関節若年性特発性関節炎治療薬の世界市場（～2026年） Market Analysis and Insights: Global Polyarticular Juvenile Idiopathic Arthritis Drug Market The global Polyarticular Juvenile Idiopathic Arthritis Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Polyarticular Juv…
- 関節リウマチ治療の世界市場（～2026年） Rheumatoid arthritis is a long-term autoimmune disorder that primarily affects joints. The rheumatoid arthritis treatment market is expected to grow over the forecast period owing to the high incidence rate of rheumatoid arthritis among people. Market Analysis and Insights: Global Rheumatoid Arthrit…
- 乾癬性関節炎治療薬の世界市場（～2026年） Psoriatic arthritis is a long-term inflammatory arthritis that occurs in people affected by the autoimmune disease psoriasis. The global psoriatic arthritis therapeutics market is expected to grow rapidly over the forecast period owing to the increasing prevalence rate of psoriatic arthritis. Market…
- 敗血症性関節炎の世界市場（～2026年） Septic arthritis is a disease caused by a bacterial infection or invasion in the joints leading to inflammation. Symptoms of septic arthritis include redness, heat, and pain in the joints reducing their movement. It is caused by bacteria, viruses, fungi, and parasites. Diabetes, osteoarthritis, gout…